Advertisement

Autonomic Hyperreflexia: Hemodynamics, Blood Volume, Serum Dopamine-β-Hydroxylase Activity, and Arterial Prostaglandin PGE2

  • N. E. Naftchi
  • M. Demeny
  • M. Berard
  • D. Manning
  • J. Tuckman

Abstract

The syndrome of autonomic dysreflexia often occurs in quadriplegic subjects and is characterized by paroxysmal hypertension, headache, vasoconstriction below and flushing of the skin above the level of transection, and bradycardia. These attacks may cause hypertensive encephalopathy, cerebral vascular accidents, and death. In five patients during crises, the mean arterial pressure changed from 95 to 154 mmHg, heart rate 72 to 45 beats/min., cardiac output 4.76 to 4.70 litres/min., and peripheral resistance 1650 to 2660 dynes. sec. cm-5. In eight subjects, the control plasma, red cell, and total blood volumes were 19.1, 10.5, and 29.6 ml/cm body height, respectively, and, when hypertensive, the plasma protein concentration increased by 9.9% and the hematocrit by 9.5%. It was estimated that plasma volume was reduced 10–15%. At that time, arterial dopamine-β-hydroxylase (DβH) activity increased 65% and prostaglandin E2 concentration by 68%. Thus, the augmented DβH activity primarily represented elevated sympathetic tone rather than hemoconcentration of that protein. It is also suggested that the rise in prostaglandin may be a contributing cause of the severe headaches during hypertensive episodes.

Keywords

Cardiac Output Plasma Volume Total Blood Volume Autonomic Dysreflexia Bladder Distension 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Agrest, A., and Roncoroni, A.J. Effect of bladder distension on pulmonary vascular bed. Circ. Res. 5: 501–505 (1960).Google Scholar
  2. Allen, A.J., and Roddie, I.C. The role of circulating catecholamines in sweat production in man. J. Physiol. 227: 801–814 (1972).PubMedGoogle Scholar
  3. Anden, N.E., Haggendal, E., Magnusson, T., and Rosengren, E. Time course of the disapperance of noradrenaline and 5-hydroxytryptamine in spinal cord after transection. Acta Physiol. Scand. 62: 115–118 (1964).PubMedCrossRefGoogle Scholar
  4. Ariefe, A.J., Tigay, E.L., and Pyzik, S.W. Acute hypertension induced by urinary bladder distension. Arch. Neurol. 2: 248–256 (1962).CrossRefGoogle Scholar
  5. Bennet, A., Friedman, C.A., and Vane, J.R. Release of prostaglandin E from the rat stomach. Nature (Lond) 216: 873 (1967).CrossRefGoogle Scholar
  6. Bevegard, S., and Oro, L. Effect of prostaglandin E1 on forearm blood flow. Scand. J. Clin. Invest. 23: 347–353 (1969).PubMedCrossRefGoogle Scholar
  7. Bors, E. The challenge of quadriplegia. Bull. Los. Angeles Neurol. Soc. 21:105–123 (1956).PubMedGoogle Scholar
  8. Brown, A.M., and Malliani, A. Spinal sympathetic relexes initiated by coronrary reflexes. J. Physiol. 212: 685–705 (1971).PubMedGoogle Scholar
  9. Braddon, R.L., Johnson, E.W. Mecamylamine in control of hyperreflexia. Arch. Phys. Med. Rehab. 50: 448–453 (1969).Google Scholar
  10. Burke, M.H., Hicks, A.F., Robins, M., and Kessler, H. Survival of patients with injuries of the spinal cord. JAMA 172: 121–124 (1960).CrossRefGoogle Scholar
  11. Carlson, L.A., Ekelund, L.G., and Oro, L. Clinical and metabolic effects of different doses of prostaglandin E1 in man. Acta Med. Scand. 183: 423–430 (1968).PubMedCrossRefGoogle Scholar
  12. Carlson, L.A., Ekelund, L.G., and Oro, L. Circulatory and respiratory effects of different doses of prostaglandin E1 in man. Acta Physiol. Scand. 75: 161–169 (1969).PubMedCrossRefGoogle Scholar
  13. Chien, S., Usami, S., Simmons, R.L., McAllister, F.F., and Gregersen, M.I. Blood volume and age: repeated measurements on normal men after 17 years. J. Appl. Physiol. 21: 583–588 (1966).PubMedGoogle Scholar
  14. Cohn, J.N. Relationship of plasma volume changes to resistance and capacitance vessel effects of sympathomimetic amines and angiotensin in man. Clin. Science 30: 267–278 (1966).Google Scholar
  15. Cunningham, D.J.C., Guttman, L., Whitterridge, D., and Wyndham, C.H. Cardiovascular responses to bladder distension in paraplegic patients. J. Physiol. 121: 581–592 (1953).PubMedGoogle Scholar
  16. Dacie, J.V., and Lewis, S.M. Practical Hematology. Fifth Edition. Churchill Livingstone, Edinburgh, London, and New York, 1975, pp. 39 - 41.Google Scholar
  17. Debarge, O., Christensen, N.J., Corbett, J.L., Eidelman, B.H., Frankel, H.L., and Mathias, C.J. Plasma catecholamines in tetraplegics. Paraplegia 12: 44–49 (1974).PubMedCrossRefGoogle Scholar
  18. Denton, I.C., White, R.P., and Robertson, J.T. The effects of prostaglandins E1, A1 and F2 α on the cerebral circulation of dogs and monkeys. J. Neurosurgery 36: 34–42 (1972).CrossRefGoogle Scholar
  19. Desmond, J. Paraplegia: problems confronting the anaesthesiologist. The Canadian Anaesthesiologists’ Soc. Jrl. 17: 435–451 (1970).CrossRefGoogle Scholar
  20. Ferreira, S.H., and Vane, J.R. Prostaglandins: Their disappearance from and release into the circulation. Nature 216: 868–873 (1967).PubMedCrossRefGoogle Scholar
  21. Finnerty, F.A., Jr., Buchholz, J.H., and Giullaudeau, R.L. The blood volumes and plasma protein during levarteronol. J. Clin. Invest. 37: 425–429 (1958).PubMedCrossRefGoogle Scholar
  22. Fox, R.H., and Hilton, S.M. Bradykinin formation in human skin as a factor in heat vasodilatation. J. Physiol. 142: 219–232 (1958).PubMedGoogle Scholar
  23. Freed, M.M., Bakst, H.J., and Barrie, D.L. Life expectancy, survival rate and causes of death in civilian patients with spinal cord trauma. Arch. Phys. Med. 47: 457–463 (1966).PubMedGoogle Scholar
  24. Freis, E.D., Standon, J.R., Finnerty, F.A., Jr., Schnaper, H.W., Johnson, R.L., Roth, C.E., and Wilkens, R.W. The collapse produced by venous congestion of the extremities and by venesection following hypotensive agents. J. Clin. Invest. 30: 435–444 (1951).PubMedCrossRefGoogle Scholar
  25. Freis, E.D., and Rose, J.C. The sympathetic nervous system, the vascular volume and the venous return in relation to cardiovascular integration. Am. J. Med. 22: 175–178 (1957).PubMedCrossRefGoogle Scholar
  26. Friedberg, C.K. Diseases of the heart. Third Edition. W.B. Saunders Company, Philadelphia 1966, p. 313.Google Scholar
  27. Friedman, S., and Kaufman, S. 3,4-Dihydroxyphenylethylamine β-hydroxylase. Physical properties, copper content, and role of copper in the catalytic activity. J. Biol. Chem. 240: 4763–4773 (1965).PubMedGoogle Scholar
  28. Gewirtz, G.P., and Kopin, I.J. Release of dopamine-β-hydroxylase with norepinephrine during cat splenic nerve stimulation. Nature (London) 227: 406–407 (1970).CrossRefGoogle Scholar
  29. Gibson, J., Peacock, W., Seligmann, A., and Sack, T. Circulating red cell volume measured simultaneously by the radioactive iron and dye methods. J. Clin. Invest. 25: 838–847 (1946).CrossRefGoogle Scholar
  30. Goldyne, M.E. Prostaglandins and cutaneous inflammation. J. Invest. Derm. 64: 377–385 (1975).PubMedCrossRefGoogle Scholar
  31. Gregersen, M.I., and Rawson, R.A. Blood volume. Physiol. Rev. 39: 307–342 (1959).PubMedGoogle Scholar
  32. Guttman, L., and Whitterridge, D. Effects of bladder distension on autonomic mechanisms after spinal cord injuries. Brain 70: 361–405 (1947).CrossRefGoogle Scholar
  33. Guyton, A.C., Jones, C.E., and Coleman, T.G. Circulatory Physiology: Cardiac output and its regulation. Second Edition. W.B. Saunders Company, Philadelphia, pp. 8–9.Google Scholar
  34. Haggendal, E., Lofgren, J., Nilsson, N.J., and Zwetnow, N.N. Effects of varied cerebrospinal fluid pressure on cerebral blood flow in dogs. Acta. Physiol. Scand. 79: 262–271 (1970).PubMedCrossRefGoogle Scholar
  35. Hall, P.V., Smith, J.E., Campbell, R.L., Felten, D.L., and Aprison, M.H. Neurochemical correlates of spasticity. Life Sci. 18: 1467–1472 (1976).PubMedCrossRefGoogle Scholar
  36. Harralson, J.D., and Brown, F.C. Inhibitors of dopamine-β-hydroxylase human plasma. Proc. Soc. Exp. Bio. and Med. 149: 643–645 (1975).Google Scholar
  37. Handa, J., Yoneda, S., Matsuda, M., and Handa, H. Effects of prostaglandins A1, E1, E2 and F2 α on canine carotid arterial blood flow, cerebrospinal fluid pressure and intraocular pressure. J. Neurosurgery 38: 32–39 (1973).CrossRefGoogle Scholar
  38. Horton, E.W. In Prostaglandins. Springer-Verlag, Berlin, New York, 1972, p. 150.Google Scholar
  39. Head, H., and Riddoch, J. Autonomic bladder, excessive seating, and some other reflex conditions in gross injuries of the spinal cord. Brain 40: 188–263 (1917).CrossRefGoogle Scholar
  40. Hodgson, N.B., and Wood, J.A. Studies of the nature of paroxysmal hypertension in paraplegics. J. Urology 79: 719–721 (1958).Google Scholar
  41. Hutch, J.A. A study of the hyperactive autonomic reflex initiated by bladder distension in patients with lesions in the cervical and high thoracic cord. J. Urology 73: 1019–1025 (1955).Google Scholar
  42. Ikeda, K., Tanaka, K., and Katori, M. Potentiation of bradykinin-induced vascular permeability increase by prostaglandin E2 and arachidonic acid in rabbit skin. Prostaglandins 10: 747–758 (1975).PubMedGoogle Scholar
  43. Johnson, B., Pallares, V., Thomason, R., and Sadove, M.S. Autonomic hyperreflexia: a review. Military Medicine 140: 345–349 (1975).PubMedGoogle Scholar
  44. Johnson, D., Thoa, N., Weinshilboum, R.M., Axelrod, J., Kopin, I.J. Enhanced release of dopamine-β-hydroxylase from sympathetic nerves by calcium and phenoxybenzamine and its reversal by prostaglandins. Proc. Nat. Acad. Sci. 68: 2227 (1971).PubMedCrossRefGoogle Scholar
  45. Karim, Sm. m., and Filshie, G.M. The use of prostaglandin E2 for therapeutic abortion. J. Obst. Gynec. Brit. Commonwealth 79: 1–13 (1972).CrossRefGoogle Scholar
  46. Koelle, G.B. Neurohumoral transmission and the autonomic nervous system. In The Pharmacological Basis of Therapeutics, Fifth Edition, L.S. Goodman and A. Gilman, MacMillan Publishing Company, Inc., New York, Chapter 21, p. 407.Google Scholar
  47. Kurnick, N.B. Autonomic hyperreflexia and its control in patients with spinal cord lesions. Annals of Internal Med. 44: 678–685 (1956).Google Scholar
  48. Lassen, N.A. Control of cerebral circulation in health and disease. Circ. Res. 34: 749–760 (1973).Google Scholar
  49. Levine, L., Gutierrez-Cernosek, R.M., and Van Vunakis, H. Specificities of prostaglandins B1, F1 α antigen-antibody reactions. J. Biol. Chem. 246: 6782 (1971).PubMedGoogle Scholar
  50. Lillienfield, L., Kovach, R. Simplified method for calculating flow, mean circulating time and downslope from indicator dilution curves. Proc. Soc. Exper. Biol, and Med. 91: 595–598 (1956).Google Scholar
  51. Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. Protein measurement with the Folin pehnol reagent. J. Biol. Chem. 193: 265 (1951).PubMedGoogle Scholar
  52. Magnusson, T., and Rosengren, E. Catecholamines of the spinal cord normally and after transection. Experimentia 19: 229–230 (1963).CrossRefGoogle Scholar
  53. Malliani, A., Peterson, D.F., Bishop, V.S., and Brown, A.M. Spinal sympathetic cardiocardiac reflexes. Circ. Res. 30: 158–166 (1972).PubMedGoogle Scholar
  54. Mertens, H.G., Harms, S., Harms, H., and Jungmann, H. The regulation of the circulation in patient swith cervical cord transection. Ger. Med. Monthly 5: 189–193 (1960).Google Scholar
  55. Naftchi, N.E., Lowman, E.W., Rusk, H., and Reich, T. Urinary catecholamine metabolites in spinal cord injured human (abstr.) Fed. Proc. 28: 544 (1969).Google Scholar
  56. Naftchi, N.E., Wooten, G.F., Lowman, E.W., and Axelrod, J. Relationship between serum dopamine-β-hydroxylase activity, catecholamine metabolism and hemodynamic changes during paroxysmal hypertension in quadriplegia. Circ. Res. 35: 850–861 (1974).PubMedGoogle Scholar
  57. Nakano, J., Chang, A.C.K., and Fisher, R.G. Effects of prostaglandins E1, E2, A1, A2 and F2 α on canine carotid arterial blood flow, cerebrospinal fluid pressure and intraocular pressure. J. Neurosurgery 38: 32–39 (1973).CrossRefGoogle Scholar
  58. Oleson, J. The effect of intracarotid epinephrine, norepinephrine and angiotensin on the regional cerebral flow in man. Neurology 22: 978–987 (1972).Google Scholar
  59. Oppenheimer, W.A. Pregnancy in paraplegic patients. Am. J. Obst. Gynec. 110: 784–786 (1971).Google Scholar
  60. Pappenheimer, J.R. Paggage of molecules through capillary walls. Phys. Rev. 33: 387–423 (1953).Google Scholar
  61. Robertshaw, D. Catecholamines and control of sweat glands in Endocrinology. Vol. VI Handbook of Physiology, pp. 591–603, Washington, D.C., 1975.Google Scholar
  62. Prout, B.J., and Wardell, W.M. Sweating and peripheral blood flow in patients with phaeochromocytoma. Clin. Sci. 36: 109–117 (1969).PubMedGoogle Scholar
  63. Robinson, B.F., Collier, J.G., Karim. S.M.M., and Somers, K. Effect of prostaglandins A1, A2, E1, E2 and F2 α on the forearm bed and superficial hand veins in man. Clin. Sci. 44: 367–376 (1973).PubMedGoogle Scholar
  64. Pelofsky, S., Jacobson, E.D., and Fisher, R.G. Effects of prostaglandins E1 on experimental cerebral vasospasm. J. Neurosurgery 36: 635–639 (1972).CrossRefGoogle Scholar
  65. Roussan, M.S., Abramson, A.S., Lippman, H.I., and D’Oronzio, G. Somatic and autonomic responses to bladder filling in patients with complete tranverse myelopathy. Arch. Phys. Med. Rehab. 47: 450–456 (1966).Google Scholar
  66. Schumacher, G.A., and Guthrie, T.C. Studies on headache: mechanisms of headache and observations on other effects induced by distension of bladder and rectum in subjects with spinal cord injuries. AMA Arch. Neurol. Psych. 65: 568–580 (1951).Google Scholar
  67. Sterling, K., and Gray, S.J. Determination of the circulating red cell volume in man by radioactive chromium. J. Clin. Invest. 29: 1614–1619 (1950).PubMedCrossRefGoogle Scholar
  68. Strandgaard, S., Oleson, J., Skinhoj, E., and Lassen, N.A. Auto-regulation of brain circulation in severe arterial hypertension. Brit. Med. J. 1: 507–510 (1973).PubMedCrossRefGoogle Scholar
  69. Tarazi, R.C., Frohlich, E.D., and Dustan, H.P. Plasma volume in men with essential hypertension. N. Eng. J. Med. 278: 762–765 (1968).CrossRefGoogle Scholar
  70. Tribe, C.R. Causes of death in the early and late stages of paraplegia. Paraplegia 1: 19–47 (1963).PubMedCrossRefGoogle Scholar
  71. Tuckman, J., Finnerty, F.A., Jr., and Buchholz, J.H. Discrepancy between body and venous hematocrits. Dilution curves of simultaneously administered I131-HSA and Cr51-labeled erythrocytes. J. Appl. Physiol. 14: 585 (1959).Google Scholar
  72. Tuckman, J., and Blumberg, A. Serial measurements of total blood volume in patients on maintenance hemodialysis. Klin. Wochenschr 54: 735–738 (1976).PubMedCrossRefGoogle Scholar
  73. Tuckman, J., Benninger, J.L., and Reubi, F. Haemodynamic and blood volume studies in long-term haemodialysis patients, and in patients with successfully transplanted kidneys. Clin. Sci. Mol. Med. 45: 155s - 157s (1973).Google Scholar
  74. Tuckman, J., and Finnerty, F.A., Jr. The cardiac index (indicator dilution method) during intravenous levarteronol infusion. Circ. Res. 7: 988–991 (1959).PubMedGoogle Scholar
  75. Vane, J.R., and McGiff, J.C. Possible contributions of endogenous prostaglandins to the control of blood pressure. Circ. Res. 36: Suppl. 1, 68–75 (1975).PubMedGoogle Scholar
  76. Verel, J. Observations on the distribution of plasma and red cells in disease. Clin. Sci. 13: 51–59 (1954).PubMedGoogle Scholar
  77. Viveros, O. H., Arqueros, L., and Kirshner, N. Release of catecholamine and dopamine-β-hydroxylase from and adrenal medulla. Life Sci. 7: 609–618 (1968).CrossRefGoogle Scholar
  78. Weeks, J.R. Prostaglandins. Annl. Rev. Pharm. 12: 317–336 (1972).CrossRefGoogle Scholar
  79. Weinshilboum, R.M., Kvetnansky, R., Axelrod, J., and Kopin, I.J. Elevation of serum dopamine-β-hydroxylase activity with forced immobilization. Nature (New Biology) 230: 287–288 (1971).CrossRefGoogle Scholar
  80. Weinshilboum, R.M., and Axelrod, J. Reduced plasma dopamine-β-hydroxylase activity in familial dysautonomia. N. Eng. J. Med. 285: 938–942 (1971).CrossRefGoogle Scholar
  81. Weinshilboum, R.M., Thoa, N.B., Johnson, D.G., Kopin, I.J., and Axelrod, J. Proportional release of norepinephrine and dopamine-β-hydroxylase from sympathetic nerves. Science 174: 1349–1351 (1971).PubMedCrossRefGoogle Scholar
  82. Wooten, G.F., and Cardon, P. Plasma D£H activity: Elevation in man during cold pressor tests and exercise. Arch. Neurol. 28: 103–106 (1973).PubMedCrossRefGoogle Scholar
  83. Wurster, R.D., and Randall, W.C. Cardiovascular responses to bladder distension in patients with spinal transection. J. Appl. Physiol. 228: 1288–1292 (1975).Google Scholar
  84. Yamamoto, Y.L., Feindel, W., Wolfe, L.S., Katoh, H., and Hodge, C.P. Experimental vasoconstriction of cerebral arteries by prostaglandins. J. Neurosurgery 37: 385–397 (1972).CrossRefGoogle Scholar
  85. Hillier, K., and Embrey, M.P. High dose intravenous administration of prostaglandin E2 and F2 α for the termination of mid-trimester pregnancies. J. Obst. Gynec. Birt. Commonwealth 79: 14–22 (1972).CrossRefGoogle Scholar

Copyright information

© Spectrum Publications, Inc. 1982

Authors and Affiliations

  • N. E. Naftchi
  • M. Demeny
  • M. Berard
  • D. Manning
  • J. Tuckman

There are no affiliations available

Personalised recommendations